Search for the latest oncology news by tumour type
Researchers identify biology behind aggressive breast cancers in Black women
Researchers at Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USA, are unlocking the…
Browsing: Tumour Stream
ESMO 2023: Cabozantinib dramatically improved progression-free survival in advanced neuroendocrine tumours
Detailed results from CABINET (A021602), a phase III pivotal trial evaluating cabozantinib compared with placebo…
ESMO 2023: Lutetium (177Lu) vipivotide tetraxetan shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive mCRPC in the pre-taxane setting
The data from the Phase III PSMAfore trial was presented at the 2023 European Society…
Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at high-risk of recurrence
An international randomised controlled trial, advised by a steering committee co-led by a senior clinician-scientist…
ESMO 2023: Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimus
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
Amivantamab plus chemo with or without lazertinib reduced risk of disease progression or death for EGFR-mutated NSCLC
The results from the Phase 3 MARIPOSA study were announced showing amivantamab-vmjw in combination with…
ESMO 2023: Amivantamab plus chemo with or without lazertinib reduced risk of disease progression or death for EGFR-mutated NSCLC
The results from the Phase 3 MARIPOSA-2 study have been announced showing the regimen of…
ESMO 2O23: Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50 percent
In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV…
Blokes get breast cancer too
When Ross Schumacher lost his mother to breast cancer 30 years ago, he had no…
